Molecular patterns of egyptian patients with non-squamous non-small-cell lung cancers: a clinicopathological study

CONCLUSION: Screening patients with newly diagnosed non-squamous NSCLC for driver mutations is essential for major prognostic and therapeutic implications. Early administration of TKIs in mutated patients significantly improves disease outcomes.PMID:37009936 | DOI:10.1186/s43046-023-00167-2
Source: J Egypt Natl Canc In... - Category: Cancer & Oncology Authors: Source Type: research